These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 6868006

  • 1. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M, Holmer E, de Mol M, Collen D.
    Thromb Haemost; 1983 Apr 28; 49(2):109-15. PubMed ID: 6868006
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin.
    Preissner KT, Müller-Berghaus G.
    J Biol Chem; 1987 Sep 05; 262(25):12247-53. PubMed ID: 2442161
    [Abstract] [Full Text] [Related]

  • 9. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
    Thomas DP, Merton RE, Barrowcliffe TW, Thunberg L, Lindahl U.
    Thromb Haemost; 1982 Jun 28; 47(3):244-8. PubMed ID: 7112499
    [Abstract] [Full Text] [Related]

  • 10. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
    Huntington JA, Gettins PG.
    Biochemistry; 1998 Mar 10; 37(10):3272-7. PubMed ID: 9521646
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
    Desai UR, Petitou M, Björk I, Olson ST.
    Biochemistry; 1998 Sep 15; 37(37):13033-41. PubMed ID: 9737884
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA, Pastorova VE, Liapina LA.
    Biokhimiia; 1981 Nov 15; 46(11):2024-9. PubMed ID: 7317530
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST, Frances-Chmura AM, Swanson R, Björk I, Zettlmeissl G.
    Arch Biochem Biophys; 1997 May 15; 341(2):212-21. PubMed ID: 9169007
    [Abstract] [Full Text] [Related]

  • 16. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
    Atkinson HM, Mewhort-Buist TA, Berry LR, Chan AK.
    Thromb Haemost; 2009 Jul 15; 102(1):62-8. PubMed ID: 19572069
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
    de Moerloose PA, Reber G, Vernet P, Minazio P, Bouvier CA.
    Thromb Haemost; 1987 Apr 07; 57(2):154-7. PubMed ID: 3603409
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The interaction of immobilized thrombin with human antithrombin III.
    Marciniak E, Gora-Maslak G.
    Thromb Haemost; 1984 Feb 28; 51(1):27-31. PubMed ID: 6719385
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.